Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rimegepant for vestibular migraine is listed as not yet recruiting, sponsored by the Second Affiliated Hospital, Zhejiang Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Vestibular Migraine, Adults 18 Years and Older (no Other Exclusion Criteria) | Phase 2 | Status: NOT_YET_RECRUITING